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INTRODUCTION 
Nicotine is a well known “nicotonic” (n) cholinergic agonist with wide- 
spread effects upon the autonomic, respiratory, and neuromuscular systems. 
By virtue of its actions on a variety of peripheral nerve receptors, it causes 
marked changes in heart rate, blood pressure, and respiration. So prominent 
are the peripheral actions of small doses of nicotine that its effects upon the 
central nervous system have been neglected or unappreciated by most inves- 
tigators interested in the pharmacology of tobacco smoking. In most studies 
of these effects, doses large enough to be toxic have been used, because the 
drug is a valuable pharmacological tool for studying cholinergic mechanisms. 
Small doses stimulate, and large doses block n cholinergic synaptic trans- 
mission. Many of the neuropharmacological and behavioral studies with 
nicotine, although of academic interest, are clearly unrelated to  tobacco 
smoking (Silvette et al., 1962). 
Our own interest in nicotine is motivated in part by the fact that  it is 
one of the few cholinergic agonists that can easily penetrate the blood-brain 
barrier. At pH 7.4 and a temperature of 37OC, the pyrrolidine nitrogen has 
been calculated to be about 69% ionized (Domino, 1965b). The 31% of 
nicotine molecules that are not ionized can readily penetrate the blood-brain 
barrier. Although the nonionized molecules are the ones that penetrate into 
various tissues, the charged form is responsible for the pharmacological effects 
(Barlow & Hamilton, 1962; Barlow, 1965). The ability of nicotine to  penetrate 
into the central nervous system has been demonstrated dramatically in both 
the mouse and the cat by Schmiterlow and Hansson (1965), using autoradio- 
graphic techniques. Even though the compound can penetrate readily into 
the brain and spinal cord, attempts to determine its direct actions upon the 
central nervous system are fraught with error because of its widespread 
peripheral autonomic effects. Because relatively small doses of nicotine, on 
the order of 5-40 pg/ kg, produce dramatic cardiovascular effects in unanes- 
thetized animals or man, we have tended to use minimal doses in most of 
our studies. 
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In this symposium, I will attempt to review and summarize the results 
obtained in my laboratory to date. This research is a collaborative effort 
involving my former graduate students and associates of the past six years, 
including Drs. Dren, Knapp, Varma, Villarreal, and Yamamoto. Some of the 
data have already been published; other portions are being prepared for 
publication in more detail in the near future. A summary of all the data and 
a synthesis of the results are presented herein. 
So far, we can say something about the actions of small doses of nicotine 
upon the central nervous system and about central cholinergic mechanisms. 
Their relationship to tobacco smoking is still unknown, but any theory of 
the cause of tobacco habituation must take into account the rather clear-cut 
central actions of very small doses of nicotine. We have used a neuro- and 
psychopharmacologic approach to determine the central actions of nicotine. 
Since nicotine releases catecholamines, serotonin, and vasopressin, these com- 
pounds have been studied as well. The effects of nicotine and related choliner- 
gic agonists were determihed in acute and chronic experiments. The actions 
of nicotine upon gross and conditioned avoidance behavior were determined 
to provide a behavioral correlate of the effects upon the central nervous 
system. 
EFFECTS OF NICOTINE UPON THE EEGs OF ANIMALS 
WITH ACUTE. TRANSECTION OF THE BRAINSTEM 
EEG Activation in Midpontine Rabbits, Cats, Dogs, 
and High-Pontine Monkeys 
It is well known that large doses of nicotine, by direct action upon the 
brain, produce a tremor which is usually followed by muscular convulsions 
(Silvette et al., 1962). Grand ma1 convulsions can be produced in most mam- 
mals. In our experience, rodents are especially easy to study in this regard. 
A large variety of anesthetic, adrenergic blocking, antihistaminic, and chol- 
inergic blocking drugs have been used as nicotinic antagonists. I t  is of interest 
that the convulsant actions of nicotine can be antagonized readily by n 
ganglionic blocking drugs which penetrate the central nervous system, especi- 
ally mecamylamine (Stone et al., 1956). Before the development of typical 
grand ma1 convulsions, an initial period of EEG desynchronization can usually 
be seen, particularly if the prior EEG pattern shows some slowing. Even if 
the drug is given in subconvulsant doses, EEG desynchronization can occur 
(Longo et al., 1954; Silvestrini, 1958; Stumpf, 1959; Dunlop et al., 1960; 
Floris et al., 1962; Silvette et al., 1962). Floris et al. (1962) reported that 
large doses of nicotine produce EEG desynchronization and seizures in 
mesencephalic-transected rabbits. These investigators suggested that the ori- 
gin of the seizure discharge was in the hippocampus. 
The site and mechanism of the action of nicotine in producing EEG 
activation was not known, because epinephrine and other substances released 
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peripherally by nicotine might account for the EEG activation observed. 
Therefore, we felt that the first problem was to show that the EEG activation 
induced by nicotine was due to direct action upon the brain (Knapp & 
Domino, 1962). Since most drugs that produce EEG activation have no 
significant effect in animals showing a baseline of EEG activation, it was 
thought to be necessary to use a preparation which had stable slow waves 
and spindles. I t  was decided to use a modification of Bremer’s (see 1953 
review) prepontine brainstem transection (classical cerueau isole‘), which results 
in EEG phenomena indistinguishable from those recorded during natural 
sleep or barbiturate hypnosis. Such a preparation is capable of showing EEG 
activation with small doses (1-4 pg/ kg) of epinephrine given intravenously 
(Bonvallet et al., 1954). 
Knapp developed an ingenious method for performing brainstem transec- 
tions by using a series of specially designed spatulas. Typical high-voltage 
slow waves and spindle bursts can be readily obtained in an intercollicular, 
midpontine, pretrigeminal brainstem transection in animals prepared acutely 
under diethyl ether anesthesia, local lidocaine, immobilization with deca- 
methonium, and artificial ventilation. Such preparations show stable EEG 
slow waves and spindles in the rabbit, cat, and dog. For example, in the dog, 
the most prominent change is the appearance of 10-14 cps spindle bursts a t  
a mean frequency + standard deviation (SD) of 13.1 + 3.0 per minute. Be- 
tween the EEG spindles, there occasionally appear slow waves and bursts 
of low-voltage, fast-frequency activity. However, no EEG activation is pro- 
duced by any of a variety of afferent stimuli. In our laboratory, such 
preparations were stable for periods up to 18 hours. Intracranial bleeding and 
cerebral edema proved to be the main problems in maintaining EEG activity 
in brainstem-transected animals. 
Several species were studied, including rabbits, cats, dogs, and monkeys. 
Electrical activity was recorded from the sensorimotor area, using both 
monopolar and bipolar recordings. The elevated skin of the scalp served as 
the reference area for the monopolar recordings. Before any drugs were tested, 
a t  least three hours were allowed for elimination of the diethyl ether anesthesia 
used in preparing the animals. 
Within one minute after the intravenous injection of 10-20 pg/kg of 
nicotine, EEG activation occurred in all four species. This is illustrated for 
the rabbit, cat, and dog in FIGURE 1. Usually within four minutes, spindle 
bursts reappeared. After six minutes, spindle bursts were the dominant feature 
of the recordings; often they were more prominent than before the nicotine 
injection. 
The actions of epinephrine and serotonin, in contrast, showed considerable 
species variation. For example, epinephrine, in intravenous doses as large 
as 8 pg/kg, did not produce EEG activation in the midpontine dog (see 
FIGURE 2) or the high-pontine monkey. Serotonin in intravenous doses of 
30 pg/ kg produced EEG activation in the midpontine rabbit and cat but 




FIGURE 1. Effect of Nicotine upon the EEG of the Midpontine Rabbit, Cat, and 
Dog. Intravenous injection of 20 pg/kg of nicotine produced EEG activation within one 
minute after injection in all species tested. Channels 1, 2, and 3 are respectively 
monopolar right somatosensory area, monopolar left somatosensory area, and bipolar 







FIGURE 2. The Effect of Epinephrine upon the EEG of the Midpontine Rabbit, Cat, 
and Dog. Intravenous injection of up to 8 pg/kg of epinephrine did not produce EEG 
activation in the midpontine dog but did in the rabbit and cat within 1 minute. Channels 
and calibration as in FIGURE 1. 
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not in the midpontine dog or high-pontine monkey. These results suggested 
that the EEG activation induced by nicotine was not due to the release from 
peripheral structures of epinephrine or serotonin which would then act upon 
the brain of the dog and monkey. 
Additional Evidence for a Direct Action of Nicotine upon the Brain 
To show that the action of nicotine upon the EEG of the midpontine dog 
was due to a direct effect upon the brain, a series of dogs was completely 
deafferented by pretrigeminal transection, section of the optic nerves, bilat- 
eral coagulation of the oculomotor nerves, and topical lidocaine anesthesia 
of the olfactory mucosa. In these animals, nicotine also produced EEG 
activation of a duration similar to that in other midpontine-transected prepa- 
rations with intact cranial nerves I, 11, and 111. 
Further evidence that nicotine induces EEG activation by a direct effect 
upon the central nervous system was provided by the dissociation between 
nicotine-induced blood pressure changes and EEG activation after the admin- 
istration of n cholinergic ganglionic blocking agents. The administration 
of hexamethonium (5 mg/ kg) or trimethidinium methosulfate (4 mg/kg) 
prevented the cardiovascular changes induced by nicotine, but not EEG 
activation. In contrast, the secondary amine, mecamylamine, also an n cho- 
linergic ganglionic antagonist, blocked the cardiovascular as well as the EEG 
activation induced by 20 pg/ kg of nicotine administered intravenously. 
Another line of evidence that the EEG activation induced by nicotine is 
not mediated by the release of peripheral stores of catecholamines or by 
changes in cerebral blood flow was obtained with the quaternary n cholinergic 
ganglionic stimulants dimethylphenylpiperazinium (DMPP) and nicotine 
monomethiodide. DMPP, in intravenous doses of 5-10 pg/kg, caused large 
but variable increases in blood pressure. Though it produced marked periph- 
eral cardiovascular changes, DMPP did not alter the EEG patterns in 
midpontine-transected dogs, nor did nicotine monomethiodide in doses of 
20-40 fig/ kg. The effects of DMPP and of nicotine are compared in FIGURE 3. 
Of considerable interest is the fact that a second dose of nicotine, given 
10 minutes after the first dose, shows tachyphylaxis in producing EEG 
activation. As shown in TABLE 1, if nicotine is given a t  intervals of less than 
15 minutes, tachyphylaxis to the induction of EEG activation is complete. 
It is necessary to wait at  least 30 minutes to  get reproducible nicotine 
EEG activation. 
To rule out the possibility that vasopressin release might account for 
nicotine-induced EEG activation, vasopressin (Pitressin) was given in large 
doses, 200 mU/kg. Although blood pressure changed markedly, there was 
no EEG activation in the midpontine-transected dog. An interesting inter- 
action between vasopressin and nicotine was observed which needs to  be 
followed further. When small doses of nicotine were administered after the 
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FIGURE 3. Specificity of Nicotine-induced EEG Activation in the Midpontine Dog. 
The illustration emphasizes two important points: (1) In contract to nicotine, DMPP 
in doses of 5-10 pg/kg does not cause EEG activation. (2) A second dose of nicotine 
10 minutes after the first dose shows marked tachyphylaxis has occurred. Channels and 
calibration as in FIGURE 1. 
injection of vasopressin, EEG activation did not occur. Intervals of a t  least 
30 minutes between injections of nicotine (to prevent possible interaction with 
the previous dose of nicotine) were necessary before EEG activation was 
elicited. Large doses of vasopressin then, a t  least initially, tended to antago- 
nize activation of the EEG by nicotine. 
Reserpine pretreatment, in intramuscular doses of 0.5 mg/kg, also had no 
significant effect upon EEG activation induced by nicotine, although the 
amounts of brainstem amines were markedly reduced (see FIGURE 4). 
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FIGURE 4. Nicotine-induced EEG Activation in the Reserpinized Midpontine Dog. 
The effects of intravenous nicotine (20 fig/ kg) were not significantly altered in animals 
given 0.5 mg/kg of reserpine intramuscularly 24 hours previously. Note that the brain- 
stem amines are markedly reduced at this time. Channels and calibration as in 
FIGURE 1. 
Site of Action of Nicotine in Inducing EEG Activation 
To identify further the precise site or circuit involved in the  activation 
of the EEG by nicotine, a series of brainstem transections was performed in 
the dog. The quaternary ganglionic blocking agent trimethidinium was given 
before the nicotine injections to prevent the considerable bleeding tha t  occurs 
due to the marked cardiovascular effects of nicotine. In  midpontine dogs 
responsive to nicotine, a higher level of transection, a t  a prepontine level, 
blocked the EEG activation of nicotine. This was not true of the cat, however; 
apparently there is a species difference. A dose of 0.25 mg/ kg of d-amphetamine 
produced EEG activation in prepontine dogs and  cats. I t  would appear tha t  
the neuronal circuits necessary for d-amphetamine-induced EEG activation 
in the dog are at a more rostra1 level than those sensitive to  nicotine. Further- 
more, the EEG activation induced by d-amphetamine lasted considerably 
longer. 
I n  isolated in vivo reticular slab experiments in the dog, it was possible 
to show that nicotine in doses of 20 pglkg produced desynchronization 
somewhat similar to that in the neocortex. This indicates that  nicotine can 
exert a desynchronizing effect upon EEG activity in an  isolated portion of 
reticular formation. These experiments have led us to conclude tha t  one site 
of action of nicotine is in some neurons of the pontine reticular formation. 
Of course, these experiments do not rule out any actions of nicotine upon 
other levels of the cerebrospinal axis. In  fact, some of our own data from cats 
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suggest that the hippocampal system is another important site of action of 
small doses of nicotine. 
Differential Receptors for EEG Activation by n and m Cholinergic 
Agonists in the Zntercollicular-High-Pontine Cat 
Since nicotine is predominantly an n cholinergic agonist, its interaction 
with predominantly “muscarinic” (m) cholinergic agonists, such as arecoline, 
was of interest. As described previously, the EEG activation induced by 
nicotine shows rapid tachyphylaxis. This phenomenon has been used to  
dissociate the types of cholinergic receptors involved in EEG desynchroniza- 
tion (Villarreal & Domino, 1964). Intercollicular, high-pontine brainstem- 
transected cats were prepared under halothane-oxygen anesthesia and 
maintained with artificial respiration. EEG desynchronization was induced 
with intravenous arecoline and/or nicotine. The peripheral autonomic effects 
of these agents were blocked with atropine methylnitrate (0.25 mg/ kg) and 
trimethidinium methosulfate (1.0 mg/kg). 
Repeated doses of nicotine, in multiples of 40.5 pg/kg, a t  one-to-10-minute 
intervals, showed rapid tachyphylaxis for EEG activation, as FIGURE 5 
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FIGURE 5.  Tachyphylaxis to the EEG Effects of Nicotine in the Brainstem- 
transected Cat. The animal was prepared under halothane anesthesia with an inter- 
collicular, high pontine transection. After recovery from anesthesia, the EEG was 
recorded bipolarly from the right to left anterior lateral gyrus (R-LALG). In panel A 
is illustrated the EEG before and one minute after 40.5 pg/kg of nicotine intravenously. 
As the dose of nicotine was progressively increased, marked tachyphylaxis to nicotine 
was observed, as shown in panels B through F. The vertical calibration bar represents 
100 microvolts, and the horizontal bar represents one second. 
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shows. Total cumulative doses of nicotine as large as 3 mg/kg in less than 
one hour were usually given. It can be seen that after an initial dose of 
40.5 pg/ kg of nicotine, EEG activation was observed; as the dose was repeated 
and increased, marked tachyphylaxis to nicotine occurred. After the adminis- 
tration of a total of 2 mg/ kg of nicotine, complete tachyphylaxis to nicotine 
was observed. Under these conditions, the administration of 77.5 pg/kg of 
arecoline, which produced EEG activation before the tachyphylaxis to nico- 
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FIGURE 6. Effects of Arecoline During Nicotine-Induced EEG Tachyphylaxis in the 
Brainstem-traneected Cat. The EEG was recorded both monopolarly and bipolarly in 
an intercollicular, high pontine-transected cat. Panel A shows the control EEG pattern 
before and after 77.5 l g /  kg of arecoline intravenously. Panel B shows the EEG pattern 
after nicotine tachyphylaxis, in which 648 pg/kg of nicotine intravenously did not cause 
EEG activation. Subsequently, as shown in Panel C, arecoline in the same dose as in 
Panel A caused EEG activation. Symbols and calibration as in FIGURE 5. 
produced EEG activation in somewhat smaller doses than arecoline, but the 
latter compound caused a more marked, dramatic, and prolonged activation. 
Another line of evidence which supports the hypothesis that m cholinergic 
receptors are independent in EEG activation was obtained with mecamyl- 
amine. As described above, this R cholinergic ganglionic antagonist can pene- 
trate more readily through the blood-brain barrier. Mecamylamine, in doses 
of 0.5 mg/ kg, blocked the EEG effects of 40.5 pg/ kg of nicotine (see FIGURE 
7), but even large doses (5.0 mg/kg) failed to block the EEG effects of 
arecoline. Whereas mecamylamine selectively blocked the activation induced 
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FIGURE 7. Specificity of Mecamylamine in Blocking the EEG Effects of Nicotine 
but not of Arecoline in the Brainstem-transected Cat. In the intercollicular, high 
pontine-transected cat, both nicotine and arecoline produced EEG activation. After 
mecamylamine (0.5 mg/kg intravenously), EEG activation by nicotine was blocked, but 
that of arecoline was still evident. Symbols and calibration as in FIGURE 5. 
by nicotine but not that  of arecoline, large doses (1.0 mg/kg) of atropine 
blocked both. 
The  hypothesis that  n cholinergic receptors are independent of each other, 
but do depend upon m cholinergic receptors for EEG activation, is further 
supported by another set of experiments. I t  has been shown (Dren & Domino, 
1965) that  hemicholinium, when injected into the lateral ventricle of the ra t  
or the  dog, produces marked EEG changes. Since hemicholinium competes 
with the uptake of choline and reduces brain acetylcholine content, it has been 
concluded that the drug acts through interference with central cholinergic 
mechanisms (Domino et ol., 1965). Large intraventricular doses (1.25 mg/kg) 
of hemicholinium, given to the intact, locally anesthetized, paralyzed, and  
artificially respired dog, produce marked neocortical as well as limbic E E G  
changes. Slow wave and spikelike E E G  phenomena induced by hemicholinium 
can be reversed by the administration of 40 pg/kg of arecoline, bu t  cannot 
be well antagonized by nicotine in comparable intravenous doses (see FIGURE 
8). Choline, physostigmine, and pilocarpine also antagonize the EEG changes 
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FIGURE 8. Differential EEG Effects of Intravenous Arecoline and Nicotine after 
Intraventricular Hemicholinium in the Dog. Hemicholinium (HC-3) was given in a total 
dose of 1.25 mg into the lateral ventricle of an intact, decamethonium-paralyzed, 
locally anesthetized dog on artificial ventilation. The control EEG was recorded mono- 
polarly from neocortical and limbic brain areas. Arterial blood pressure was recorded 
as well. Panels A and B illustrate the differential effects of arecoline and nicotine 
given 2-4 hours after HC-3. HC-3 produced marked EEG changes in both neocortical 
and limbic structures. These changes were reversed by arecoline in a dose of 40 pg/kg 
given intravenously. On the other hand, nicotine, in the same dose, did not produce 
nearly as dramatic an EEG reversal in the neocortex and produced none in the 
hippocampus. Methylatropine was given in a dose of 0.125 mg/kg intravenously before 
arecoline to reduce its peripheral cardiovascular effects. Symbols: L.Prc2-motor cortex; 
L.Prc1-sensory cortex; L.01-left occipital cortex; L.AMYG-left basolateral amygdala; 
L. Dorsal Hipp-left dorsal hippocampus. All EEG recordings were monopolar, referred 
to the nasion. Femoral arterial blood pressure was recorded on channel 6 and calibrated 
in mm HG. Vertical bars for voltage calibration, 100 microvolts. 
induced by  hemicholinium, but &amphetamine does not. These experiments 
indicate t h a t  brain structures contain a t  least two types of cholinergic recep- 
tors capable of inducing EEG desynchronization. The n cholinergic receptor 
mechanisms appear  t o  be less effective t h a n  t h e  m cholinergic receptor mech- 
anisms for inducing EEG activation in  both  the c a t  a n d  the dog. 
EFFECTS OF NICOTINE IN CATS WITH 
CHRONICALLY INDWELLING BRAIN ELECTRODES 
Acute E E G  studies provide little information about  t h e  behavioral con- 
sequences of nicotine. I n  animals with intact  brains, EEG desynchronization 
recorded from neocortical structures can  occur in  at  least t w o  different 
behavioral states: (a) wakefulness, and (b) the act ivated,  "paradoxical," or  
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fast-wave phase of sleep (Dement & Kleitman, 1957; Dement, 1958; Yama- 
moto, 1959; Jouvet, 1961; Yamamoto & Kido, 1962. To  ascertain whether 
the EEG desynchronizing actions of nicotine are related to behavioral arousal 
or to the fast-wave phase of sleep, it was necessary to study the effects of 
nicotine upon intact animals with chronically implanted brain electrodes. 
This we have done using cats (Yamamoto & Domino, 1965; Domino & 
Yamamoto, 1965). Various pharmacological pretreatments were given using 
the strategy and knowledge obtained from the acute experiments, to deter- 
mine whether the actions of nicotine observed were due primarily to peripheral 
or central components. 
Effects of Small Doses of Nicotine upon the EEG 
and Behavioral Stages of Sleep 
Cats were selected because they readily sleep during the daytime and 
show a fairly regular sleep-wake cycle. The circadian sleep and waking 
patterns of the laboratory cat have recently been described in detail by 
Sterman et al. (1965). Our animals were routinely studied in the daytime. 
The study was performed in 15 cats with chronically indwelling electrodes 
in the somatosensory cortex, the hippocampus, the amygdala, the posterior 
hypothalamus, and the midbrain reticular formation. The animals were pre- 
pared with indwelling brain electrodes by conventional stereotoxic techniques. 
For intravenous injection, Silastic tubing was used for an indwelling cannula 
in the jugular vein. All surgery was performed under pentobarbital anesthesia. 
Two weeks of convalescence were allowed before the experimental studies. 
When the animals recovered fully from the operative procedures, they were 
placed in a warm, soundproof, insulated box which had a one-way window 
for observation. The natural sleep-awake cycle of each animal was then 
recorded throughout the experimental day. All medications were given in an 
incomplete Latin square design. 
Intravenous infusions of warmed physiological saline, in doses of 1.5 to 
2.0 ml, given over a one-minute period, had no significant EEG or behavioral 
consequences in cats which were in natural slow-wave (deep) sleep, as evi- 
denced behaviorally and by the EEG. In  contrast, nicotine in doses of 
5-10 pg/ kg produced three distinct EEG and behavioral phenomena. The 
first was a brief period (approximately three minutes) of neocortical desyn- 
chronization and hippocampal theta activity, accompanied by behavioral 
wakeup from natural slow-wave sleep. Then the animals lapsed into slow-wave 
sleep again, as evidenced behaviorally and by the EEG; often they slept more 
deeply than before the nicotine injection. After about 15-25 minutes, an 
increased incidence of activated sleep was observed. These EEG effects of 
nicotine are illustrated in FIGURE 9. The changes in EEG, electrocardiogram 
(EKG), and respiration can be plotted over a period of time in the form of a 
line graph to illustrate more clearly the phenomena observed (see FIGURE 10). 
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FIGURE 9. EEG Effects of Nicotine in the Cat with Chronically Indwelling Brain 
Electrodes. Nicotine (10 gg/ kg) was given intravenously between the two arrows during 
slow-wave sleep. Note the changes in EEG activity and behavior. The upper two records 
are continuous; the lower are 9 and 16 minutes later. All recordings were bipolar. 
Symbols: L. POST. SIC. = left posterior s i p o i d  gyms; L. AMY. = left amygdala; 
L. POST. HYP. = left post hypothalamus; L. HIP. = left hippocampus; EMG = electro- 
myograph of neck muscles; RESP. = thoracic respiration. Voltage calibrations are 
as indicated. 
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FIGURE 10. Effects of Nicotine in the Cat. The EEG stages and heart and respiration 
rates per minute are plotted for 20 minutes before and after intravenous nicotine. The 
data were obtained from the same cat whose EEG is shown in FIGURE 9. 
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Differential Receptors for EEG Activation and Behavioral Arousal 
for n and m Cholinergic Agonists 
The EEG and behavioral effects of nicotine in the intact animal could 
be due to a variety of phenomena. Even though it had been shown that the 
predominant site of action for EEG activation by nicotine in the acute 
brainstem-transected preparation was central, this remained to  be proved in 
chronic experiments with intact cats. I t  was decided to study the effects of 
nicotine before and after the administration of various n and m cholinergic 
antagonists with predominantly peripheral and/or central actions. Two m 
cholinergic antagonists were chosen: methylatropine, with predominantly 
peripheral actions; and atropine, with both peripheral and central actions. 
Two n cholinergic ganglionic antagonists were also chosen: trimethidinium, 
with predominantly peripheral actions; and mecamylamine, with both periph- 
eral and central actions. Since large doses of either atropine or mecamylamine 
interfered with the sleep cycle of the cat, doses of these compounds were 
kept small. 
As can be seen in FIGURE 11, only mecamylamine completely prevented 
the EEG and behavioral arousal effects of nicotine. This is in marked contrast 
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FIGURE 11. Modification of the Effects of Nicotine by Various rn and A Cholinergic 
Antagonista in the Cat. The doses of various agents given intravenously are listed. 
Approximately 180 or more minutes elapsed after each pretreatment given on different 
days before nicotine was injected; this was to achieve stable conditions of sleep. Note 
that only after mecamylamine were the effects of nicotine abolished. 
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to the EEG and behavioral arousal effects of arecoline, which were blocked 
only by atropine (see FIGURE 12). These data confirm the conclusions 
obtained in the acute experiments described above. Thus m and n cholinergic 
receptors in the brain are capable of producing EEG activation and behavioral 
arousal, and the effects of arecoline last longer and are more dramatic than 
those of nicotine. 
Since cats with chronic indwelling brain electrodes vary widely in their 
patterns of arousal and sleep, it was felt necessary to quantitate the various 
stages of sleep for periods up to 25 minutes before and after the injection 
of nicotine and arecoline, in animals pretreated with various cholinergic 
antagonists. The data for all cats studied are summarized in bar graphs of 
each EEG stage as mean percentage f standard error (SE) (see FIGURES 13 
and 14). 
After the administration of saline, the cats showed varying percentages 
of the alert, resting, drowsy, slow-wave, and fast-wave sleep states. After an 
intravenous dose of 10 pg/ kg of nicotine, the percentage of alertness increased. 
This was accompanied by a decrease in drowsiness and slow-wave sleep, and 
was followed by a definite increase in the percentage of fast-wave sleep. 
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FIGURE 12. Modification of the Effects of Arecoline by Various rn and R Cholinergic 
Antagonists in the Cat. The doses of various agents given intravenously are listed. No 
two pretreatments were given on any one day. When stable conditions for sleep were 
obtained, arecoline (40 pglkg) was given. Note that only atropine abolished the effects of 
arecoline. Even large doses (0.6 mg/kg) of methylatropine did not block the EEG effects 
of arecoline. 
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SALINE 1.5 ML 
NICOTINE 
0.01 MG/KG 
FIGURE 13. Mean Percentage of Each EEG State of Sleep 25 Minutes after Nicotine 
Injection following Pretreatment with Various m and n Cholinergic Antagonists. The 
graph summarizes the mean f SE of nine cats for each EEG state after various 
pretreetments, as shown. Note that both atropine and, especially, mecamylamine block 
the increase in percentage of alert state after nicotine injection. Both methylatropine 
and trimethidinium reduced this percentage. Marked individual variability was observed, 
as the large SE's show. 
Atropine blocked these effects of nicotine; the cat remained primarily in 
slow-wave sleep. Somewhat similar findings were noted after the administra- 
tion of methylatropine. Trimethidinium reduced the altering effects of nico- 
tine only slightly, but mecamylamine blocked them. In contrast with the 
effects of nicotine, arecoline produced a much longer duration of alerting but 
no significant increase in fast-wave sleep (see FIGURE 14). Atropine blocked 
completely the actions of arecoline, but methylatropine only reduced them. 
After either trimethidinium or mecamylamine, arecoline was even more effec- 
tive in causing EEG and behavioral arousal. The significance of this finding 
is not known. I t  would appear that  the same specificity of rn and n cholinergic 
agonists and antagonists, as demonstrated in acute animals, applies to cats 
with chronically indwelling brain electrodes. 
Comparison of the Effects of Nicotine and Other Cardiovascular Drugs 
upon the EEG Stages of Sleep 
Since small doses of nicotine have marked cardiovascular effects, par- 
ticularly in unanesthetized animals, it  was of interest to determine the effects 
of other cardiovascular drugs upon the EEG.  Therefore, nine cats were studied 
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SALINE 1.5MI 
AREGOLINE 
0.04 W K G  
FIGURE 14. Mean Percentage of Each EEG State of Sleep 26 Minutes after Arecoline 
Injection following Pretreatment with Various m and n Cholinergic Antagonists. The 
graph is similar to that in FIGURE 13. Note that atropine was the only agent that 
completely blocked the effects of arecoline. After atropine alone, the animals showed 
a marked increase in slow-wave sleep. 
before and after treatments with: saline, 1.5 ml; nicotine, 10 pg/kg; epi- 
nephrine, 2 pg/kg; DMPP, 5 pg/kg; arginine vasopressin, 50 mPu/kg; 
lysine vasopressin, 50 mPu/ kg; phenylalanine lysine vasopressin (PLV-2), 
50 mPu/kg; or angiotensin, 2 pglkg. Since the alerting effects of nicotine 
are relatively transient, the percentages of EEG levels 5 and 25 minutes before 
and after administration of these drugs were compared. A modified Latin 
square design was used in which the cats were tested a t  intervals of one to 
three days between drugs. 
As FIGURE 15 shows, nicotine caused a marked increase in the mean 
percentage of EEG and behavioral arousal for a 5-minute period after injec- 
tion. This effect was accompanied by a decrease in the amount of time spent 
in the drowsy state and in slow-wave sleep. Somewhat similar effects were 
produced by epinephrine, DMPP, the vasopressins, and angiotensin. From 
these findings, i t  is obvious that a large variety of cardiovascular agents can 
produce a brief wake-up effect, primarily by peripheral actions. Comparison 
of the percentage of EEG stages 25 minutes before and after the same drugs 
shows that the percentage of sleep after nicotine was not markedly altered, 
although the amount of fast-wave sleep increased (see FIGURE 16). It is 
interesting that epinephrine, DMPP, lysine vasopressin, and angiotensin did 
not significantly increase fast-wave sleep, although arginine vasopressin and, 
especially, PLV-2 were effective. 
It can be concluded that nicotine, in doses of 10 pg/kg, given over a 
one-minute period, produces transient behavioral arousal and EEG activation 
in cats with chronically indwelling brain electrodes. The effects of nicotine 
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FIGURE 15. Mean Percentages of Time Spent by Cats in Different EEG States 
5 Minutes before and after Various Pretreatments. The pooled control data before and 
after saline injection show similar trends. Note, however, that all the drugs increase 
the amount of time spent in alertness, reflecting peripheral afferent stimulation from 
rises in blood pressure, etc. This contributes to the wake-up effect in intact animals. All 
drugs were given over a one-minute period in the doses listed. The drugs were injected 
during slow-wave sleep. The data represent a mean *SE of 5-15 cats. 
were evident chiefly when the animals were in natural slow-wave sleep, as 
observed behaviorally and by EEG recordings from various cortical and 
subcortical sites. After nicotine administration, the animals were aroused for 
a few minutes and later became behaviorally sleepy and showed EEG slow 
waves. This was frequently followed by fast-wave sleep. This latter effect 
of nicotine has also been observed by Jewett and Norton (1965). 
Approximately equipressor doses of a variety of cardiovascular drugs 
produce similar EEG activation and behavioral arousal phenomena. Obvious- 
ly, in an intact animal given nicotine, the release of various neurohumors, 
such as vasopressin and epinephrine, contributes to  the EEG activation and 
behavioral arousal effects. As noted previously, pretreatment with trimeth- 
idinium (2 mg/ kg) prevented the cardiovascular effects of nicotine and re- 
duced, but did not block, the behavioral arousal and EEG activating actions. 
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FIGURE 16. Mean Percentage of Time Spent by Cats in Different EEG States 
25 Minutes before and after Various Pretreatments. The data from the same experiments 
as in FIGURE 15 are plotted for a 25-minute period to illustrate especially the changes 
in fast-wave sleep. Note that only nicotine and the vasopreseins increased the per- 
centages of fast-wave sleep. PVL-2 and arginine vasopressin were much more effective 
than lysine vasopressin in equal millipressor units. These compounds were kindly 
provided by Sandoz Pharmaceuticals. 
By such pharmacological techniques, i t  can be concluded that the behavioral 
arousal and EEG desynchronizing effects of nicotine are due primarily to  an 
action on the central nervous system; but, as might well be expected, the 
release of various neurohormones or stimulation of the peripheral afferents 
contributes to the total phenomenon seen in intact animals. 
FAILURE OF SMALL DOSES OF NICOTINE GIVEN AT BEDTIME 
TO ALTER THE SLEEP CYCLE OF NORMAL HUMAN VOLUNTEERS 
In  view of the fact tha t  nicotine and vasopressin transiently increase the 
amount of wakefulness and fast-wave sleep in the  cat, i t  was thought to be 
important to determine whether these findings apply to man (Varma & 
Domino, 1966). Eight normal male university students were selected for 
subjects on the basis of (a) signed written consents; (b) no evidence of 
psychosis, organicity, convulsive disorders, etc.; (c) between 18 and 30 years 
of age; (d) were normal from the point of view of history and physical 
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examination, including a diagnostic EEG; and (e) had no medication for a t  
least one month before the study. Light smokers (less than one pack a day) 
and nonsmokers participated. The subjects took no alcohol or cigarettes after 
6:OO p.m. on the evening of the study. They were unaware of the medications 
they were receiving. 
Drug dosage, given intramuscularly, was as follows: nicotine tartrate, 
15 pg/ kg; lysine vasopressin or phenylalanine lysine vasopressin, (PLV-2) 
50 mPu/kg; or 2.0 ml of physiological saline. The subjects had a t  least one 
night of habituation, with the electrodes applied, before actual trials. Medica- 
tion was administered a t  the hour of sleep (1O:OO-10:30 p.m.). Each subject 
then slept continuously for a t  least seven hours. Recordings were made 
throughout the night. They included monopolar EEGs to both ears (as 
reference), the electro-oculogram (EOG) from left to right eye, and EKG 
lead 11. The polygraph records were analyzed according to  Dement and 
Kleitman’s (1957) classification of sleep, as modified by Williams et al. (1964). 
I t  was noted that physiological saline affected significantly the sleep cycle 
of normal volunteers (see TABLE 2). The percentage of fast-wave sleep 
(Stage I)  increased from a mean SE of 20.9 + 2.2 to 25.7 + 2.5 after saline. 
The intramuscular administration of nicotine frequently caused a stinging 
sensation a t  the site of injection. Within one minute, some of the subjects 
19.2 2.5 
TABLE 2 
LACK OF SIGNIFICANT EFFECTS OF NICOTINE AND VASOPRESSIN UPON THE 
EEG STAGES OF SLEEP IN NORMAL HUMAN VOLUNTEERS. 
23.8 +. 2.6 




2 ml I 8 I 1.9 k 0 . 5  
I I 
Nicotine I 7 I 2 . 1 ~ 0 . 8  
15 pLg/kg 
Lysine 
vasopressin I 8 1 1.0 i o . 2  
50 mU/kg 
1 8 I 1 . 2 k 0 . 3  PLV-2 50 mU/kg 
24.7 f 3.0 32.4 k 4.5 
28.6 +. 3.Ot I 36.4 * 2.9 
24.9 +. 1.6 128.1 L 2.1 
III 
17.1 2 3.7 
20.9 2.4 
N 
22.5 f 1.7 
23.0 k 2.8 
15.1 +. 1.9 18.8 +. 3.6 
25.7 5 3.3t I 20.1 f 2.5 
- 
*All injections were given intramuscularly. 
?Differs significantly from No medication. Paired comparison, Student ‘t,* 
P < .05. 
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felt “dizzy,” “light-headed,” and nauseated. This feeling seldom lasted more 
than 5 minutes. Usually, the subjects fell asleep about the same time as after 
the saline injection and showed no striking alteration in their sleep behavior. 
Immediately after the injections of nicotine, the heart rates increased slightly. 
Lysine vasopressin and, especially PLV-2, in doses of 50 mPu/kg, occa- 
sionally caused a decrease in heart rate which lasted less than one hour. During 
this time, some subjects complained of a slight uneasiness and the feeling 
of having to move their bowels. These were not prominent symptoms, and 
the subjects usually fell asleep promptly. In comparison to no medication, 
lysine vasopressin increased significantly the percentage of Stage I, from a 
mean =t SE of 20.9 f 2.2 to 28.6 f 3.0. PLV-2 also increased significantly the 
amount of Stage 111. Lysine vasopressin was more effective than PLV-2 in 
shortening the time between the injection and the onset of Stage I. 
In this very preliminary study, six of the eight subjects were nonsmokers 
and the other two were light smokers, averaging less than 1 pack of cigarettes 
per day. No differences between light smokers and nonsmokers were observed 
in onset, duration, pattern of sleep, or responses to nicotine. One can conclude 
that under the conditions of this study, in which nicotine was given a t  
bedtime, no evidence of a wake-up effect or facilitation of Stage I sleep was 
obtained. The reason may be that the action of nicotine is relatively short, 
so that the compound could hardly be expected to alter a sleep cycle 7-8 hours 
long. The vasopressins also had no significant effects upon the sleep cycle 
under these circumstances. However, this needs to be studied further. 
BEHAVIORAL ACTIONS OF NICOTINE IN THE RAT 
Differential Effects upon Latency of Avoidance 
in “Slow” us. “Fast” Rats 
There have been many studies of the behavioral effects of nicotine in 
animals and man (see Silvette et al., 1962). One can summarize the litera- 
ture by saying that nicotine has little to no effect, and that when it does 
act, it is either a stimulant or a depressant according to dose, duration of 
treatment, behavioral task, and species. Our interest in the behavioral effects 
of nicotine developed from a desire to understand the significance of the 
EEG activation it induces. As already noted, the EEG actions are rather 
transient. Nevertheless, in cats, they are associated with behavioral arousal 
and are followed by an increase in fast-wave sleep. It can be predicted that 
this brief wake-up effect observed in the EEG can be shown to have behavior- 
al correlates under the proper experimental circumstances. 
It has been previously reported (Domino, 1965a) that nicotine in large 
doses has marked effects upon conditioned avoidance behavior in the rat. The 
action of large doses of nicotine upon established conditioned pole-jumping 
behavior is reminiscent of the effects of chlorpromazine. These actions are 
produced by relatively large doses of nicotine and therefore are probably 
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unrelated to the effects of the small doses absorbed during tobacco smoking, 
In our experiments, nicotine has shown no consistent effect upon the acquisi- 
tion of conditioned avoidance behavior. I t  has been possible upon occasions 
to show that nicotine, in small doses, facilitates acquisition and delays extinc- 
tion, but that large doses have reproducibile depressant actions. We reported 
these findings a t  the Tobacco Symposium in Stockholm (Domino, 1965a). 
At that  time, Bovet (1965) and Bovet-Nitti (1965) pointed out that small 
doses of nicotine have facilitating effects upon behavior, especially in the 
naive rat. These effects were considered to be similar to those of amphetamine, 
and different from those of chlorpromazine and other related drugs. The 
Bovets emphasized some very important facts: I t  was necessary to use 
split-litter techniques to reduce variability. Furthermore, by using separate 
“bright” and “dull” groups of rats, they were able to demonstrate the 
facilitating effects of nicotine, especially in slow learners. Our own data have 
indicated that the EEG-activating actions of nicotine, or its behavioral wake- 
up effect in chronic cats, appeared only when the dose was administered 
during a state of mild central nervous system depression or sleep. This suggests 
that nicotine should have an alerting effect upon behavior only in fatigue 
states or other states of slight central nervous system depression. The degree 
of depression must be slight, however; because barbiturates, even in small 
doses, easily block nicotine’s EEG activating effects. 
We have previously reported that small doses of nicotine have no consis- 
tent effect upon the response latency for conditioned avoidance behavior 
in monkeys (Domino, 1965a). On the other hand, Bovet-Nitti (1965) has been 
able to show a reduction in reaction times following nicotine. We have re- 
examined this problem from the point of view of the effect of nicotine in 
animals with “fast” vs. “slow” latency times for conditioned avoidance pole 
jumping. In a modification of the original Cook and Weidley (1957) technique, 
rats were trained to react to a buzzer stimulus to avoid an electric shock 
applied to the grid floor. A 5-second buzzer tone was the conditioned stimulus 
(CS), and a 5-second, 1 milliampere, 60 cps electroshock was the uncondi- 
tioned stimulus (US); these were used under overlap conditions. Male Holtz- 
man rats of 200-500 gm were employed. The rats were trained in blocks of 
20 trials to a total of 200 trials for a 90% avoidance criterion. Animals not 
reaching this criterion were discarded. 
On the day of testing, the trained rats were given 20 control trials and 
60 postdrug trials. Within each block of 20 trials, there were random intertrial 
intervals with a mean duration of 45 seconds; the interval between blocks 
was three minutes. Latency of avoidance and escape were measured auto- 
matically. Nicotine was given in doses of 40, 80, and 160 pg/kg as base, 
subcutaneously. Physiological saline was given in comparable volumes, which 
did not exceed 0.5 ml. After the 20 control trials, the drug was injected; 
then, after a one-minute wait, the postdrug trials began. The mean avoidance 
latency f SE for saline and for increasing doses of nicotine, for groups of six 
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or more rats selected a t  random, are shown in FIGURE 17. It can be seen that 
after saline and 40 pg/kg of nicotine, there was a tendency for the mean 
avoidance latency to increase with the number of trial blocks. This trend was 
reversed after the administration of 80 and 160 pg/ kg of nicotine, especially 
for postnicotine trials 1-20 and 21-40. A dose of 40 pg/kg of nicotine was not 
significantly different from saline in altering the percentage of avoidance 
behavior in postinjection trials 1-20. However, 80 pg/kg caused a 1.3% 
reduction of avoidance behavior, and 160 pg/kg caused a 4% reduction. 
Therefore, another experiment was run in which 12 trained rats were given 
20 control trials, followed by saline injection and one US. Then the normal 
CS-US sequence was run in blocks of 20 trials. This experiment mimicked 
the actions of nicotine by causing an automatic 5% increase in the number 
of escape responses. Under these circumstances the mean avoidance latency 
*SE was 1.59 * 0.12 before injection, and 1.41 * 0.16 for post-injection trials 
1-20,1.65 *0.19 for trials 21-40, and 1.79 *0.16 for trials 41-60. These effects 
with saline plus electroshock are almost identical with those obtained after 
nicotine (see FIGURE 18). The slight increase in the number of escape 
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FIGURE 17. Effects of Increasing Doses of Nicotine upon Mean Avoidance Latency 
for Pole Jumping in Trained Rats. The mean latencies A SE, in seconds, of groups of 
6 or more rats given either saline or various doses of nicotine subcutaneously are shown. 
The mean latencies of 20 control trials before injection are followed by the mean latencies 
of postinjection blocks of 20 trials each. Note that latencies for saline and for 4Opg/kg 
of nicotine increased with each block of trials. On the other hand, 80 and 160 pg/kg of 
nicotine temporarily reverse this trend for the first and second postinjection blocks. 
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FIGURE 18. Similarity of Effect of Saline plus Electroshock to that of Nicotine upon 
Mean Avoidance Latencies for Conditioned Pole Jumping in Rats. After saline injection 
and one unconditioned stimulus, the subsequent mean avoidance latencies were decreased 
to the same extent as after nicotine. 
responses due to exposure to electroshock after nicotine might account for 
the decrease in latency, since one postsaline US speeds up subsequent avoid- 
ance responses. 
A dose of 80 pg/ kg of nicotine produced much less depression of avoidance 
behavior and an even greater decrease in mean avoidance latency than 
160 pg/kg of nicotine. It seemed that the speed-up effect of nicotine was not 
associated only with its ability to decrease conditioned avoidance behavior 
and thus increase the motivation of the rats due to exposure to  electroshock 
during the US interval. A large number (30) of trained rats were given 
80 pg/kg of nicotine each and tested for the latency of pole jump avoidance 
as described above. The  animals were divided into two groups, one “fast” and  
the other “slow,” on the basis of their control avoidance latencies. The  
differential effects of saline and nicotine are graphed in FIGURE 19. Saline 
and nicotine caused the same prolongation of mean avoidance latency in the  
“fast” rats. The nicotine-treated rats tended to  be slightly faster, but the 
standard errors overlapped with those for saline except for postinjection 
trials 41-60. On the other hand, the “slow” rats given nicotine showed a 
definite decrease in mean latency compared to those given saline, especially 
in postinjection trials 1-20 and 21-40. This decrease was statistically signifi- 
cant (P < 0.05). Nicotine reduced avoidance behavior in both groups during 
postinjection trials 1-20 (see FIGURE 20), by 3.7% for the “fast” group and 
5.7% for the “slow” group. Is it possible that this 2% difference in exposure 
to electroshock can account for such dramatic differences? Since electroshock 
is an effective motivator, one would be inclined to answer yes, although 
further work must obviously be done to prove this. I t  should be noted tha t  
during postinjection trials 21-40 there was no reduction of avoidance behavior 
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FIGURE 19. Differential Effects of Nicotine upon the Mean Avoidance Latencies for 
Pole Jumping in “Fast” vs. “Slow” Rats. The mean latencies ~t SE in seconds of groups 
of 15 or more rats given saline or nicotine in a subcutaneous dose of 80 pg/  kg are shown. 
“Fast” rats, whether treated with saline or with nicotine show similar trends for slower 
mean avoidance latencies after injection. The “slow” rats treated with saline show a 
similar trend. However, ‘‘slow’’ rats treated with 80 pg/kg of nicotine show a temporary 
speed-up for the first and second postinjection trial blocks. 
in either group, yet the mean avoidance latency of the slow rats was still less 
than that of the saline-treated “slow,” or saline- or nicotine-treated “fast” 
rats. However, similar effects were noted with saline plus electroshock. 
SUMMARY 
There are two different reasons for interest in the actions of nicotine on 
the central nervous system. One is related to the presence of nicotine in 
tobacco, possibly serving as a reinforcer of the habit of smoking tobacco. The 
other is the use of nicotine to  increase the understanding of cerebral cholinergic 
mechanisms. These two interests are quite compatible, particularly if small 
doses of nicotine are used. For the past six years, research in our laboratory 
has been directed toward elaborating the central actions of nicotine. To date, 
we can say something about the actions of small doses of nicotine upon the 
central nervous system and central cholinergic mechanisms. Their relationship 
to tobacco smoking is still unknown, but the fact that very small doses of 
nicotine cause rather clear-cut central actions suggests that  any theory of the 
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FIGURE 20. Differential Effects of Nicotine upon Mean Percentage of Avoidance 
Response in “Fast” and “Slow” Rats. The mean SE percentage of avoidance responses 
for pole jumping are plotted. Note that nicotine at 80 pg/kg depressed avoidance 
behavior in the “slow” rats slightly more than in the “fast” ones. Thus, the findings 
given in FIGURE 19 may be related to the number of electroshocks obtained from failure 
to avoid when under the influence of nicotine. 
cause or maintenance of tobacco smoking must take into account these phar- 
macological facts. 
If one were arbitrarily choosing a drug for studying its possible actions 
on the central nervous system, perhaps no poorer choice could be made than 
nicotine. This agent has so many pharmacological actions tha t  they easily 
confound, reinforce, and obscure its direct central actions. As a n  n cholinergic 
agonist, nicotine acts a t  a variety of sites in the peripheral nervous system. 
These multiple actions must be considered in any study of nicotine’s effects 
upon the central nervous system. 
We have used a neuro- and psychopharmacologic approach to determine 
the central actions of nicotine. Since nicotine releases acetylcholine, catechol- 
amines, serotonin, and vasopressin, these compounds were studied as well. 
The effects of nicotine and related drugs upon the  EEGs  of acute and chronic 
animals were determined. I n  addition, the effects of nicotine upon gross and 
conditioned avoidance behavior were studied to provide behavioral correlates 
of the EEG changes. 
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Nicotine, in doses of 5-20 pg/kg i.v., causes EEG activation in acute 
experiments which is related to a behavioral wake-up effect. This action, 
which lasts only a few minutes, involves both central and peripheral com- 
ponents. Nicotine also causes an  increase in fast-wave sleep, which may be 
related to vasopressin release. The  initial behavioral consequences of small 
doses of nicotine are consistent with a brief wake-up effect. 
In rats trained to pole jump, nicotine in subcutaneous doses of 80 and  
160 pg/ kg produced a transient decrease in mean avoidance latency within 
one or two minutes. In contrast, saline or 40 pg/kg of nicotine, produced a 
slight increase in avoidance latency. Mean avoidance latency decreased more 
in “slow” rats than in “fast” ones. The  effects of nicotine were highly 
significant; the role of slightly increased percentages of unconditioned stimuli 
(electroshock) in increasing motivation in the nicotine-treated animals needs 
to be studied further. 
In conclusion, the research reported here indicates tha t  nicotine, in doses 
comparable to those absorbed by a man smoking tobacco, has pharmacological 
actions consistent with a brief wake-up effect as well as a transient period 
of mild central nervous system depression. The behavior depressant effects 
of nicotine are more evident with larger doses. 
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